20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Understanding DEHP in Medical Devices: Safety Concerns and Regulatory Responses

Medical devices are indispensable tools in modern healthcare, often requiring materials that are flexible, durable, and cost-effective. Polyvinyl Chloride (PVC) is a widely used material in this sector, and its flexibility is typically achieved through the addition of plasticizers, most commonly Di(2-ethylhexyl) phthalate (DEHP), also known as Dioctyl Phthalate (DOP). While DEHP has served the medical industry for decades, its use has become a subject of increasing concern due to potential health risks associated with its leaching from devices into patients.

DEHP is added to PVC to make it soft and pliable, crucial for devices such as IV bags, blood bags, tubing, catheters, and dialysis equipment. However, studies have indicated that DEHP can leach out of the PVC matrix, particularly when exposed to heat or when in contact with lipids or certain medications. Once in the body, DEHP is metabolized into compounds that have been linked to adverse health effects, including endocrine disruption, reproductive toxicity, developmental issues in children, and potential carcinogenicity. These concerns are particularly acute for vulnerable patient populations, such as neonates and critically ill individuals undergoing long-term medical treatments.

In response to these growing concerns, regulatory bodies worldwide have begun to implement stricter controls on the use of DEHP in medical devices. In the United States, for example, California has passed legislation to phase out DEHP in certain medical devices, with specific timelines for its prohibition in intravenous solution containers and tubing. This move by California, a significant market, often influences broader national and international regulatory trends. The U.S. Food and Drug Administration (FDA) has also issued guidance and recommendations regarding the use of DEHP, encouraging manufacturers to explore and adopt safer alternatives.

In Europe, the Medical Device Regulation (MDR) has also increased scrutiny on substances like DEHP. Manufacturers are required to demonstrate the safety of the materials used in their devices, and the use of Substances of Concern, including certain phthalates, is subject to rigorous evaluation and potential restriction. This regulatory pressure, combined with an increasing demand from healthcare providers for DEHP-free alternatives, is driving innovation in the field of medical-grade plasticizers.

Companies like NINGBO INNO PHARMCHEM CO.,LTD. are at the forefront of this transition, offering a range of advanced, phthalate-free plasticizers that meet the stringent requirements of the medical device industry. These alternatives are designed to provide comparable flexibility and performance to DEHP while offering a significantly improved safety profile. The shift away from DEHP is a critical step in ensuring patient safety and aligning medical device manufacturing with the growing global emphasis on chemical safety and public health.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: The Role of Plasticizers in Enhancing PVC Performance and Applications

Next: The Environmental Footprint of Plasticizers: Understanding Impacts and Seeking Sustainable Solutions

All Rights Reserved